Patients with head and neck cancer: Are they frailer than patients with other solid malignancies?
- PMID: 31571340
- PMCID: PMC7063690
- DOI: 10.1111/ecc.13170
Patients with head and neck cancer: Are they frailer than patients with other solid malignancies?
Abstract
Objective: We aimed to compare frailty status between patients with head and neck cancer (HNC) and other solid malignancies.
Methods: Data collection was prospective, and the following were compared between cohorts at baseline: patient and tumour characteristics, Charlson Comorbidity Index (CCI), Groningen Frailty Indicator (GFI), Mini Mental State Examination (MMSE), Activities of Daily Living (ADLs), Instrumental ADLs (IADLs), Timed Up and Go (TUG) and Quality of Life (QoL). Univariate and multivariate logistic regression analyses were performed, and odds ratios (ORs) with their 95% confidence intervals (95% CIs) were estimated.
Results: In total, 242 patients with HNC and 180 with other oncology diagnoses were enrolled, of whom 32.6% and 21.8% were frail according to the GFI respectively. Comorbidity scores were not significantly different between the cohorts (7.4% vs. 13.1%; OR 0.54; 95% CI 0.28-1.02). In the univariate analysis, the GFI was significantly worse in the HNC cohort (OR 1.74; 95% CI 1.11-2.71). However, in the multivariate analysis, the MMSE, TUG and global QoL were significantly worse in the HNC cohort, with ORs of 20.03 (95% CI 2.44-164.31), 11.56 (95% CI 1.86-71.68) and 0.98 (95% CI 0.97-1.00) respectively.
Conclusion: Patients with HNC appear to be frailer than patients with other solid malignancies despite comparable levels of comorbidity.
Keywords: frail elderly; frailty; geriatric assessment; geriatric oncology; head and neck cancer; quality of life.
© 2019 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd.
Conflict of interest statement
All authors have no conflict of interest to declare.
References
-
- Aaronson, N. K. , Ahmedzai, S. , Bergman, B. , Bullinger, M. , Cull, A. , Duez, N. J. , … Takeda, F. (1993). The european organization for research and treatment of cancer QLQ‐C30: A quality‐of‐life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. 10.1093/jnci/85.5.365 - DOI - PubMed
-
- American Joint Committee on Cancer (AJCC) (2010). What is cancer staging?. Retrieved from https://cancerstaging.org/references-tools/Pages/What-is-Cancer-Staging..... Accessed 30/11, 2017.
-
- Bøje, C. R. , Dalton, S. O. , Primdahl, H. , Kristensen, C. A. , Andersen, E. , Johansen, J. , … Overgaard, J. (2014). Evaluation of comorbidity in 9388 head and neck cancer patients: A national cohort study from the DAHANCA database. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 110(1), 91–97. 10.1016/j.radonc.2013.11.009 - DOI - PubMed
-
- Bras, L. , Peters, T. , Wedman, J. , Plaat, B. , Witjes, M. , van Leeuwen, B. L. , … Halmos, G. B. (2015). Predictive value of the groningen frailty indicator for treatment outcomes in elderly patients after head and neck, or skin cancer surgery in a retrospective cohort. Clinical Otolaryngology: Official Journal of ENT‐UK; Official Journal of Netherlands Society for Oto‐Rhino‐Laryngology & Cervico‐Facial Surgery, 40(5), 474–482. 10.1111/coa.12409 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
